Prof. Yan Zhu (Tianjin, China)
Dr. Zhu received PhD in Microbiology (2013) from University of Chinese Academy of Sciences. He then joined the University of Queensland and worked on food microbiology. In 2015, He joined Monash University and worked on systems pharmacology. In 2022, he took a full-time Professor position at Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences and works on systems biology. His research is well funded by Tianjing Synthetic Biotechnology Innovation Capacity Improvement Project (2022-2025), CAS Pioneer Initiative Action (2024-2026), National Key Research and Development Program of China (2023-2028), CAS Progress of Strategy Priority Research Program C (2024-2026).
He has published two book chapters, and 91 peer-reviewed papers thus far. His recent first-authored research paper on polymyxin-dependence was featured on the front cover of Advanced Science in 2020. The novel synthetic lipopeptide antibiotic paper published on Nature Communications 2022 was selected as Editorials’ Highlights. He serves as a member of Technical Committee of Computational Synthetic biology, Chinese Bioinformatics Society, and an Associate Editor of International Journal of Antimicrobial Agents, Gene Reports, SynBio, and Synthetic Biology and Engineering.
Dr. Zhu received PhD in Microbiology (2013) from University of Chinese Academy of Sciences. He then joined the University of Queensland and worked on food microbiology. In 2015, He joined Monash University and worked on systems pharmacology. In 2022, he took a full-time Professor position at Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences and works on systems biology. His research is well funded by Tianjing Synthetic Biotechnology Innovation Capacity Improvement Project (2022-2025), CAS Pioneer Initiative Action (2024-2026), National Key Research and Development Program of China (2023-2028), CAS Progress of Strategy Priority Research Program C (2024-2026).
He has published two book chapters, and 91 peer-reviewed papers thus far. His recent first-authored research paper on polymyxin-dependence was featured on the front cover of Advanced Science in 2020. The novel synthetic lipopeptide antibiotic paper published on Nature Communications 2022 was selected as Editorials’ Highlights. He serves as a member of Technical Committee of Computational Synthetic biology, Chinese Bioinformatics Society, and an Associate Editor of International Journal of Antimicrobial Agents, Gene Reports, SynBio, and Synthetic Biology and Engineering.